Needham & Company reiterated a Buy rating and $60.00 price target on G1 Therapeutics (NASDAQ: GTHX) after spending time with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE